Amyloid targeting imaging agents and uses thereof

Details Amyloid targeting imaging agents and uses thereof Amyloid targeting imaging agents and uses thereof

2007-12-25

2007-12-25

Hartley, Michael G. (Department: 1618)

Drug, bio-affecting and body treating compositions

In vivo diagnosis or in vivo testing

Reexamination Certificate

active

10728028

ABSTRACT:
Amyloid-targeting imaging agents such as radiolabeled amyloid targeting molecules and amyloid targeting molecule-chelator conjugates for imaging, e.g., amyloid plaques in vivo, and/or for the treatment of amyloidosis disorders. The invention provides amyloid-targeting imaging agents that are useful for imaging sites of amyloid disease. Imaging agents of the invention are capable of binding specifically to amyloid plaques, as an aid in diagnosis and/or early treatment of amyloidosis disorders.

REFERENCES:
patent: 4647447 (1987-03-01), Gries et al.
patent: 4666829 (1987-05-01), Glenner et al.
patent: 4885363 (1989-12-01), Tweedle et al.
patent: 4899755 (1990-02-01), Lauffer et al.
patent: 4957939 (1990-09-01), Gries et al.
patent: 5066789 (1991-11-01), Srinivasan et al.
patent: 5088499 (1992-02-01), Unger
patent: 5219554 (1993-06-01), Groman et al.
patent: 5362475 (1994-11-01), Gries et al.
patent: 5431900 (1995-07-01), Bergstein et al.
patent: 5480970 (1996-01-01), Pollak et al.
patent: 5558854 (1996-09-01), Quay
patent: 5569286 (1996-10-01), Peckham et al.
patent: 5573751 (1996-11-01), Quay
patent: 5589154 (1996-12-01), Anderson
patent: 5637759 (1997-06-01), Hearst et al.
patent: 5643562 (1997-07-01), Kisilevsky et al.
patent: 5659041 (1997-08-01), Pollak et al.
patent: 5662885 (1997-09-01), Pollak et al.
patent: 5674470 (1997-10-01), Tweedle et al.
patent: 5676925 (1997-10-01), Klaveness et al.
patent: 5725373 (1998-03-01), Yeh
patent: 5795562 (1998-08-01), Klaveness et al.
patent: 5820850 (1998-10-01), Hashimoto et al.
patent: 5840294 (1998-11-01), Kisilevsky et al.
patent: 5846519 (1998-12-01), Tweedle et al.
patent: 5928626 (1999-07-01), Klaveness et al.
patent: 5972328 (1999-10-01), Kisilevsky et al.
patent: 5976501 (1999-11-01), Jablonski
patent: 6033645 (2000-03-01), Unger et al.
patent: 6053930 (2000-04-01), Ruppert
patent: 6054114 (2000-04-01), Lansbury, Jr. et al.
patent: 6071495 (2000-06-01), Unger et al.
patent: 6083484 (2000-07-01), Lohrmann et al.
patent: 6096782 (2000-08-01), Audia et al.
patent: 6123920 (2000-09-01), Gunther et al.
patent: 6139819 (2000-10-01), Unger et al.
patent: 6146657 (2000-11-01), Unger et al.
patent: 6191166 (2001-02-01), Audia et al.
patent: 6197040 (2001-03-01), LeVaughn et al.
patent: 6207856 (2001-03-01), Veech
patent: 6211235 (2001-04-01), Wu et al.
patent: 6261537 (2001-07-01), Klaveness et al.
patent: 6274119 (2001-08-01), Barrio et al.
patent: 6670399 (2003-12-01), Green et al.
patent: 2002/0020087 (2002-02-01), Griffith
patent: WO-00/64420 (2000-11-01), None
patent: WO0064420 (2000-11-01), None
patent: WO-01/39796 (2001-06-01), None
patent: WO-01/87534 (2001-11-01), None
patent: WO-02/24652 (2002-03-01), None
Amedio, J.C. et al., “Preparation of N,N-Bis[2-N'N'-Bis[(Tert-Butoxycarbonyl) Methyl]-Amino]Ethyl-L-Aspartic Acid: An Intermediate In The Synthesis Of MRI Contrast Agents,”Synthetic Communications, vol. 30(20):3755-3763 (2000).
Pollack, Scott J. et al., “Sulfonated dyes attenuate the toxic effects of β-amyloid in a structure-specific fashion,”Neuroscience Letters, vol. 197:211-214 (1995).
Rudyk, Hélène et al., “Screening Congo Red and its analogues for their ability to prevent the formation of PrP-res in scrapie-infected cells,”Journal of General Virology, vol. 81:1155-1164 (2000).

Affiliated with

Also associated with

Rating

Amyloid targeting imaging agents and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Amyloid targeting imaging agents and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amyloid targeting imaging agents and uses thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3883075